British journal of cancer
Völler D, Bosserhoff A.
PMID: 24556619
Br J Cancer. 2014 Oct 14;111(8):1673. doi: 10.1038/bjc.2014.57. Epub 2014 Feb 20.
No abstract available.
Cite
Völler D, Bosserhoff A. Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences. Br J Cancer. 2014;111(8):1673doi: 10.1038/bjc.2014.57.
Völler, D., & Bosserhoff, A. (2014). Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences. British journal of cancer, 111(8), 1673. https://doi.org/10.1038/bjc.2014.57
Völler, D, and Bosserhoff, A. "Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences." British journal of cancer vol. 111,8 (2014): 1673. doi: https://doi.org/10.1038/bjc.2014.57
Völler D, Bosserhoff A. Reply to comment on: Strong reduction of AGO2 expression in melanoma and cellular consequences. Br J Cancer. 2014 Oct 14;111(8):1673. doi: 10.1038/bjc.2014.57. Epub 2014 Feb 20. PMID: 24556619; PMCID: PMC4200103.
Copy
Download .nbib
Current pharmaceutical design
Greenberg E, Nemlich Y, Markel G.
PMID: 24479804
Curr Pharm Des. 2014;20(33):5246-59. doi: 10.2174/1381612820666140128210105.
Melanoma is a high-grade, poorly differentiated malignant tumor of pigment-producing cells (melanocytes), accounting for more than 70% of the skin cancer related deaths. Although new lines of targeted therapy and immunotherapy were introduced lately, durable responses are not common...
Cite
Greenberg E, Nemlich Y, Markel G. MicroRNAs in cancer: lessons from melanoma. Curr Pharm Des. 2014;20(33):5246-59doi: 10.2174/1381612820666140128210105.
Greenberg, E., Nemlich, Y., & Markel, G. (2014). MicroRNAs in cancer: lessons from melanoma. Current pharmaceutical design, 20(33), 5246-59. https://doi.org/10.2174/1381612820666140128210105
Greenberg, Eyal, et al. "MicroRNAs in cancer: lessons from melanoma." Current pharmaceutical design vol. 20,33 (2014): 5246-59. doi: https://doi.org/10.2174/1381612820666140128210105
Greenberg E, Nemlich Y, Markel G. MicroRNAs in cancer: lessons from melanoma. Curr Pharm Des. 2014;20(33):5246-59. doi: 10.2174/1381612820666140128210105. PMID: 24479804.
Copy
Download .nbib
